Helping biopharma companies achieve the highest probability of commercial success
The biopharma market landscape is dynamic. Constantly moving goal posts require an ability to anticipate every potential play along the way, ensuring the right investments are made to maximize ROI, accelerate commercial success, and deliver on promises to patients.
Similar to a contract commercial organization (CCO), we’ve supported the commercialization of more products than any other partner. But being big doesn’t make us best; scale with intentional flexibility does. We meet our customers where they are in the drug commercialization process, designing and implementing customized, repeatable solutions with exceptional scale and agility.
For small innovative biopharmaceutical companies with limited commercial resources, we can provide end-to-end commercialization capabilities through our Full-Service Commercialization
For larger biopharma companies looking to supplement expertise, we can offer custom solutions with a strategic mix of proprietary services and purpose-built infrastructure, including:
Deployment Solutions that include insight and commercialization
Consulting capabilities that accelerate your commercial success; or
Healthcare Communications to ensure on-point messaging.
As a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success, we’re able to integrate strategic, creative and operational expertise across all aspects of commercialization, from regulatory and medical affairs, to market access and sales and marketing.
Next is now
The pharma commercial model of the (very near) future is being built on today’s key drivers of customer engagement:
Entrepreneurial field leadership
Medical domain expertise
Omnichannel engagement and amplification
Precision data analytics
Syneos Health can give you all that and more, bringing together human understanding of behavioral motivators
with therapeutic expertise, and sophisticated data intelligence - all with the goal to accelerate commercial success,
deliver more predictable growth, and drive access and adoption at launch.
Seeing new market realities and pathways to success
In an industry with limited sharing of best practices, we make it a habit to share our experiences and insights, while using sophisticated data intelligence to turn those insights into action.
This deep learning results in tightly connected strategy and execution, allowing our customers to focus on what they do best – concentrate on the science behind the most innovative and efficacious therapeutics.